If You Invested in Quantumzyme (QTZM)

Quantumzyme Corp (QTZM) is a Nevada corporation whose common stock trades under the ticker symbol QTZM. According to its public filings, the company is incorporated in the State of Nevada and maintains principal executive offices in San Diego, California. Quantumzyme Corp is subject to U.S. securities regulations and files reports with the Securities and Exchange Commission (SEC) under Commission File Number 000-56725.

Based on available regulatory disclosures, Quantumzyme Corp has undertaken corporate actions focused on its identity and governance structure. These actions are reflected in amendments to its Articles of Incorporation, as approved by its Board of Directors and the holder of a majority of the voting power of its outstanding capital stock. Such amendments are part of the company’s formal corporate records and are implemented in accordance with Nevada corporate law and federal securities law requirements.

Corporate Name Change to Quantum Genesis AI Corp

In an 8-K filing, Quantumzyme Corp reported that its Board of Directors approved an amendment to the company’s Articles of Incorporation to change its corporate name from Quantumzyme Corp to Quantum Genesis AI Corp. The majority stockholder approved this name change by written consent. The company indicated that a Certificate of Amendment would be filed with the Nevada Secretary of State after completion of its Schedule 14C information statement process and the expiration of the applicable 20-day waiting period required under federal securities laws.

The company also reported that it filed an Issuer Company-Related Action Notification Form with FINRA in connection with the proposed name change and the application for a new stock symbol. According to the filing, the name change is not expected to affect shareholder rights and will not change the company’s authorized capital, issued and outstanding shares, CUSIP number, or par value. A new ticker symbol is expected to be assigned by FINRA upon completion of its review of the corporate action request.

Regulatory and Corporate Structure

Quantumzyme Corp operates within the framework of U.S. public company regulation. Its disclosures indicate that it uses information statements on Schedule 14C when seeking stockholder consent for certain corporate actions, and that it coordinates with FINRA for changes that affect how its securities are identified and traded in the market. These steps reflect the company’s obligations to follow federal securities laws and self-regulatory organization procedures when modifying key aspects of its corporate profile.

Because available public information focuses primarily on corporate governance and name-change actions, detailed information about Quantumzyme Corp’s industry, operating activities, or revenue model is not specified in the cited filings. Investors and researchers relying on the QTZM symbol should be aware that the company has disclosed its intention to transition its corporate name to Quantum Genesis AI Corp, subject to completion of the regulatory and corporate processes described in its SEC reports.

Trading Symbol and Shareholder Considerations

The company’s 8-K disclosure notes that, following regulatory review, a new stock symbol will be assigned by FINRA in connection with the name change. Until that process is completed and becomes effective, QTZM remains the historical ticker symbol associated with Quantumzyme Corp. The company has stated that the name change itself will not alter the number of authorized or outstanding shares, the CUSIP number, or the par value of its stock, and that shareholder rights are not expected to be affected by this specific corporate action.

For investors, this means that the reported changes relate to the company’s corporate identity and how it is referenced in the market, rather than to a recapitalization or change in basic share terms as described in the cited filing. Further details about the company’s operations, business strategy, or sector focus would need to be obtained from additional filings or disclosures beyond the information summarized here.

Company Status and Historical Context

As of the most recent referenced 8-K filing, Quantumzyme Corp remains a Nevada corporation with disclosed plans to change its name to Quantum Genesis AI Corp and to obtain a new trading symbol. The filing does not state that the company has been delisted, deregistered, acquired, or placed into bankruptcy. Accordingly, QTZM represents the historical symbol for Quantumzyme Corp during the period covered by the filing, while the company has signaled an intention to operate under a new corporate name once the formal processes are completed.

Because the available information centers on governance and naming matters, this overview focuses on those confirmed facts. Prospective investors and researchers should review the company’s full SEC filings for a more complete picture of its activities, risks, and corporate evolution.